The Ids have it
- PMID: 21156278
- DOI: 10.1016/j.ccr.2010.11.028
The Ids have it
Abstract
In this issue of Cancer Cell, Anido et al. demonstrate that Id1 is the likely arbiter of divergent transforming growth factor-β (TGF-β) signaling in glioma-initiating cells (GICs) from different tumors. These findings hold both the promise and potential peril of therapeutic targeting of the TGF-β pathway.
Copyright © 2010 Elsevier Inc. All rights reserved.
Comment on
-
TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma.Cancer Cell. 2010 Dec 14;18(6):655-68. doi: 10.1016/j.ccr.2010.10.023. Cancer Cell. 2010. PMID: 21156287
Publication types
LinkOut - more resources
Full Text Sources
